Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers

ABSTRACT:

SUBMITTER: Sergi B 

PROVIDER: S-EPMC12334744 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature